Cerity Partners’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Buy
44,929
+15,734
+54% +$1.15M ﹤0.01% 1285
2026
Q1
$1.91M Sell
29,195
-25,076
-46% -$1.86M ﹤0.01% 1520
2025
Q4
$4.3M Buy
54,271
+9,817
+22% +$752K 0.01% 986
2025
Q3
$3.25M Sell
44,454
-127
-0.3% -$9.31K 0.01% 1070
2025
Q2
$3.38M Sell
44,581
-2,885
-6% -$204K 0.01% 985
2025
Q1
$3.61M Buy
47,466
+1,294
+3% +$96.4K 0.01% 861
2024
Q4
$3.08M Sell
46,172
-6,547
-12% -$458K 0.01% 921
2024
Q3
$3.68M Buy
52,719
+11,337
+27% +$682K 0.01% 833
2024
Q2
$2.19M Buy
+41,382
New +$2.51M 0.01% 872

Other funds holding SOLV

Cerity Partners's SOLV Position: Q2 2026 in Review

Cerity Partners increased its Solventum (SOLV) stake by 54% in Q2 2026, buying an estimated $1.15M and bringing the position to 44,929 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1285.

Cerity Partners first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.3M in Q4 2025. 835 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Cerity Partners held 44,929 shares of Solventum worth $3.47M as of Q2 2026.
  • Cerity Partners bought 15,734 Solventum shares in Q2 2026, an estimated $1.15M.
  • Solventum made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1285 holding.
  • Cerity Partners first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Cerity Partners's Solventum position peaked at $4.3M in Q4 2025.
  • 835 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.